Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

  • Potential role of bcr-abl in the activation of JAK1 kinase.
    Y C Henderson, X Y Guo, J Greenberger and A B Deisseroth
    Clin Cancer Res February 1 1997 3 (2) 145-149;

  • Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein.
    S R Husain, N I Obiri, P Gill, T Zheng, I Pastan, W Debinski and R K Puri
    Clin Cancer Res February 1 1997 3 (2) 151-156;

  • Induction of transforming growth factor beta-1 in cervical intraepithelial neoplasia in vivo after treatment with beta-carotene.
    J T Comerci Jr, C D Runowicz, A L Fields, S L Romney, P R Palan, A S Kadish and G L Goldberg
    Clin Cancer Res February 1 1997 3 (2) 157-160;

  • Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide.
    C P Dinney, C Parker, Z Dong, D Fan, B Y Eve, C Bucana and R Radinsky
    Clin Cancer Res February 1 1997 3 (2) 161-168;

  • Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
    A H Sarris, D Daliani, R Ulmer, M Crow, H E Broxmeyer, M Reiss, N Karasavvas, A D Zelenetz, W Pugh, F Cabanillas, A B Deisseroth and M Duvic
    Clin Cancer Res February 1 1997 3 (2) 169-177;

  • In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma.
    E D Liaudet-Coopman, G J Berchem and A Wellstein
    Clin Cancer Res February 1 1997 3 (2) 179-184;

  • Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    S M Overholt, T J Liu, D L Taylor, M Wang, A K El-Naggar, E Shillitoe, K Adler-Storthz, L S John, W W Zhang, J A Roth and G L Clayman
    Clin Cancer Res February 1 1997 3 (2) 185-191;

  • High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
    M deMagalhaes-Silverman, E Bloom, B Lembersky, J Lister, S Pincus, W Rybka, M Voloshin, J Wilson and E Ball
    Clin Cancer Res February 1 1997 3 (2) 193-197;

  • Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
    S Krajewski, A D Thor, S M Edgerton, D H Moore 2nd, M Krajewska and J C Reed
    Clin Cancer Res February 1 1997 3 (2) 199-208;

  • Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
    T O Frommel, M Dyavanapalli, T Oldham, N Kazi, H Lietz, Y Liao and S Mobarhan
    Clin Cancer Res February 1 1997 3 (2) 209-213;

  • Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
    C S Ha, F Cabanillas, M S Lee, P C Besa, P McLaughlin and J D Cox
    Clin Cancer Res February 1 1997 3 (2) 215-219;

  • A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
    C Scheibenbogen, K H Lee, S Mayer, S Stevanovic, U Moebius, W Herr, H G Rammensee and U Keilholz
    Clin Cancer Res February 1 1997 3 (2) 221-226;

  • 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas.
    G Fontanini, S Vignati, S Chiné, M Lucchi, A Mussi, C A Angeletti, S Ménard, V Castronovo and G Bevilacqua
    Clin Cancer Res February 1 1997 3 (2) 227-231;

  • Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients.
    J Grøndahl-Hansen, I J Christensen, P Briand, H Pappot, H T Mouridsen, M Blichert-Toft, K Danø and N Brünner
    Clin Cancer Res February 1 1997 3 (2) 233-239;

  • Microsatellite instability is correlated with lymph node-positive breast cancer.
    L De Marchis, A Contegiacomo, C D'Amico, R Palmirotta, C Pizzi, L Ottini, P Mastranzo, M Figliolini, G Petrella, C Amanti, P Battista, A R Bianco, L Frati, A Cama and R Mariani-Costantini
    Clin Cancer Res February 1 1997 3 (2) 241-248;

  • Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.
    S W Melchior, E Corey, W J Ellis, A A Ross, T J Layton, M M Oswin, P H Lange and R L Vessella
    Clin Cancer Res February 1 1997 3 (2) 249-256;

  • In vitro and in vivo induction of apoptosis by sphingosine and N, N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells.
    T Shirahama, E A Sweeney, C Sakakura, A K Singhal, K Nishiyama, S Akiyama, S Hakomori and Y Igarashi
    Clin Cancer Res February 1 1997 3 (2) 257-264;

  • Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995).
    R Danesi, C Agen, U Benelli, A D Paolo, D Nardini, G Bocci, F Basolo, A Campagni and M D Tacca
    Clin Cancer Res February 1 1997 3 (2) 265-272;

  • Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
    M Drees, W A Dengler, T Roth, H Labonte, J Mayo, L Malspeis, M Grever, E A Sausville and H H Fiebig
    Clin Cancer Res February 1 1997 3 (2) 273-279;

  • Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model.
    E G Hanania and A B Deisseroth
    Clin Cancer Res February 1 1997 3 (2) 281-286;

  • 9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer.
    P L de Souza, M R Cooper, A R Imondi and C E Myers
    Clin Cancer Res February 1 1997 3 (2) 287-294;

  • Improvement of in vitro chemosensitivity assay for human solid tumors by application of a preculture using collagen matrix.
    A Kitaoka, R Muraoka and N Tanigawa
    Clin Cancer Res February 1 1997 3 (2) 295-299;

  • Retroviral transfer of a bacterial alkyltransferase gene (ada) into human bone marrow cells protects against O6-benzylguanine plus 1, 3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
    U K Marathi, L C Harris, C C Venable and T P Brent
    Clin Cancer Res February 1 1997 3 (2) 301-307;

  • Modulation of 5-fluorouracil in mice using uridine diphosphoglucose.
    G Codacci-Pisanelli, J Kralovanszky, C L van der Wilt, P Noordhuis, J R Colofiore, D S Martin, F Franchi and G J Peters
    Clin Cancer Res February 1 1997 3 (2) 309-315;

Back to top
PreviousNext
February 1997
Volume 3, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement